Tags

Type your tag names separated by a space and hit enter

Tetanus vaccines: WHO position paper, February 2017 - Recommendations.
Vaccine. 2018 06 14; 36(25):3573-3575.V

Abstract

This article presents the World Health Organization's (WHO) recommendations on the use of tetanus toxoid (TT) vaccines excerpted from the WHO position paper on tetanus vaccines - February 2017, published in the Weekly Epidemiological Record [1]. This position paper replaces the May 2006 WHO position paper on tetanus vaccines (Tetanus vaccines: WHO position paper, 2006). The position paper summarizes the recent developments in the field of tetanus prevention and provides revised guidance on the optimal timing of recommended tetanus vaccine booster doses. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of TT-containing vaccines (TTCVs) were discussed by SAGE in October 2016; evidence presented at the meeting can be accessed at: http://www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/.

Authors+Show Affiliations

WHO, Immunization, Vaccines and Biologicals, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28427847

Citation

World Health Organization. Electronic address: sageexecsec@who.int. "Tetanus Vaccines: WHO Position Paper, February 2017 - Recommendations." Vaccine, vol. 36, no. 25, 2018, pp. 3573-3575.
World Health Organization. Electronic address: sageexecsec@who.int. Tetanus vaccines: WHO position paper, February 2017 - Recommendations. Vaccine. 2018;36(25):3573-3575.
World Health Organization. Electronic address: sageexecsec@who.int. (2018). Tetanus vaccines: WHO position paper, February 2017 - Recommendations. Vaccine, 36(25), 3573-3575. https://doi.org/10.1016/j.vaccine.2017.02.034
World Health Organization. Electronic address: sageexecsec@who.int. Tetanus Vaccines: WHO Position Paper, February 2017 - Recommendations. Vaccine. 2018 06 14;36(25):3573-3575. PubMed PMID: 28427847.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tetanus vaccines: WHO position paper, February 2017 - Recommendations. A1 - ,, Y1 - 2017/04/18/ PY - 2017/02/14/received PY - 2017/02/15/accepted PY - 2017/4/22/pubmed PY - 2018/9/27/medline PY - 2017/4/22/entrez KW - Maternal and neonatal tetanus elimination (MNTE) KW - Tetanus vaccines KW - Tetanus-toxoid-containing vaccines (TTCV) KW - Vaccine position paper KW - WHO position paper SP - 3573 EP - 3575 JF - Vaccine JO - Vaccine VL - 36 IS - 25 N2 - This article presents the World Health Organization's (WHO) recommendations on the use of tetanus toxoid (TT) vaccines excerpted from the WHO position paper on tetanus vaccines - February 2017, published in the Weekly Epidemiological Record [1]. This position paper replaces the May 2006 WHO position paper on tetanus vaccines (Tetanus vaccines: WHO position paper, 2006). The position paper summarizes the recent developments in the field of tetanus prevention and provides revised guidance on the optimal timing of recommended tetanus vaccine booster doses. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of TT-containing vaccines (TTCVs) were discussed by SAGE in October 2016; evidence presented at the meeting can be accessed at: http://www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/28427847/Tetanus_vaccines:_WHO_position_paper_February_2017___Recommendations_ L2 - https://www.clinicalkey.com/content/playBy/pii?v=S0264-410X(17)30228-1 DB - PRIME DP - Unbound Medicine ER -